News & Analysis on Clinical Trial Services & Contract Research And Development
With colorectal cancer (MRC) being the second biggest cancer type in Hong Kong, it is positive news that Hutchmed has received marketing approval for its Elunate (fruquintinib) small molecule treatment.
Two new offerings have been unveiled by drug delivery and solutions provider, Stevanto Group S.p.A.
Clinical programmers can now further accelerate clinical study reporting, submission analysis and statistical modeling and more thanks to a new product in EDETEK’s informatics platform, Conform.